Cachexia is a wasting syndrome characterized by pronounced skeletal muscle loss.  In cancer, cachexia associates with increased morbidity and mortality and decreased treatment tolerance.;	Although advances have been made in understanding the mechanisms of cachexia, translating these advances to the clinic has been challenging. One reason for this shortcoming may be the current animal models that fail to fully recapitulate the etiology of;	human cancer-induced tissue wasting. Because pancreatic ductal adenocarcinoma (PDA) presents with a high incidence of cachexia, we engineered a mouse model of PDA, that we named KPP. KPP mice, similar to PDA patients, progressively lose skeletal and adipose mass;	as a consequence of their tumors. In addition, KPP muscles exhibit a similar gene ontology to cachectic patients. We envision the KPP model will be a useful resource for advancing our mechanistic understanding and ability to treat cancer cachexia. SOURCE: Erin Talbert Medical University of South Carolina

Pluto Bioinformatics

GSE133524: Modeling Human Cancer-induced Cachexia (Mouse)